BACKGROUND AND AIM: Osteomyelitis of the foot is the most commonly encountered complication in diabetic patients. Nuclear medicine techniques are usually complementary to radiology in the diagnosis of foot infections; they play an important role in various clinical situations. The aim of this study was to develop a practical guideline to describe the radiopharmaceuticals to be used for different clinical conditions and different aims in diabetic foot infection. METHODS: In this study, we reviewed 57 papers (published between 1982 and 2004; 50 original papers and seven reviews) that described the imaging of the diabetic foot and examined a total of 2889 lesions. We performed data analysis to establish which imaging technique could be used as a 'gold standard' to diagnose infection, evaluate the extent of disease and monitor the efficacy of therapy. RESULTS AND CONCLUSION: We provide a guideline to assist in the selection of the optimal radiopharmaceuticals for different clinical conditions and different aims.
BACKGROUND AND AIM: Osteomyelitis of the foot is the most commonly encountered complication in diabeticpatients. Nuclear medicine techniques are usually complementary to radiology in the diagnosis of foot infections; they play an important role in various clinical situations. The aim of this study was to develop a practical guideline to describe the radiopharmaceuticals to be used for different clinical conditions and different aims in diabetic foot infection. METHODS: In this study, we reviewed 57 papers (published between 1982 and 2004; 50 original papers and seven reviews) that described the imaging of the diabetic foot and examined a total of 2889 lesions. We performed data analysis to establish which imaging technique could be used as a 'gold standard' to diagnose infection, evaluate the extent of disease and monitor the efficacy of therapy. RESULTS AND CONCLUSION: We provide a guideline to assist in the selection of the optimal radiopharmaceuticals for different clinical conditions and different aims.
Authors: Francisco Lazaga; Suzanne Av Van Asten; Adam Nichols; Kavita Bhavan; Javier La Fontaine; Orhan K Oz; Lawrence A Lavery Journal: Int Wound J Date: 2015-04-08 Impact factor: 3.315
Authors: Erik F J de Vries; Manel Roca; Francois Jamar; Ora Israel; Alberto Signore Journal: Eur J Nucl Med Mol Imaging Date: 2010-04 Impact factor: 9.236
Authors: Rosario Morales Lozano; Maria L González Fernández; David Martinez Hernández; Juan V Beneit Montesinos; Sagrario Guisado Jiménez; Maximo A Gonzalez Jurado Journal: Diabetes Care Date: 2010-07-09 Impact factor: 19.112
Authors: Andor W J M Glaudemans; Erik F J de Vries; Liliane E M Vermeulen; Riemer H J A Slart; Rudi A J O Dierckx; Alberto Signore Journal: Eur J Nucl Med Mol Imaging Date: 2013-07-17 Impact factor: 9.236
Authors: William A Erdman; Ji Buethe; Rafia Bhore; Hans K Ghayee; Chiarra Thompson; Param Maewal; Jon Anderson; Steve Klemow; Orhan K Oz Journal: Diabetes Care Date: 2012-06-20 Impact factor: 19.112